Mst1^−/− mice exhibit decreased incidence and severity of CIA. by Konstantin V. Salojin (567844)

<i>Kpna1</i> KO mice show decreased anxiety-like behavior in the elevated plus maze. by Koki Sakurai (11690201)

Up-regulation of <i>ATP5J</i> expression enhanced cell migration and decreased 5-Fu sensitivity in DLD1 cells. by Hongbo Zhu (14981)

Mutation of stathmin phosphorylation sites decreases sensitivity to bortezomib and influences tubulin polymerization. by Feng Ge (64593)

Osteoclast differentiation in cultures of bone marrow cells from WT and <i>Gli1</i>^+/− mice. by Yoshiaki Kitaura (644233)

Fig 5 - by Jie He (132999)

Normal TLR4 and MD2 expression and decreased IL10 secretion and A20 expression by <i>cpdm</i> BMDC. by Zhe Wang (41178)

Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

“…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”

The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

Infection with BVDV R₂, R₃ and R₅ leads to a decrease in dead cells. by Eliana F. Castro (581093)

Acute exercise decreased plasma insulin and glucose. by Mirian A. Kurauti (3146271)

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced degranulation. by Jian Hao (160736)

Increased endodiastolic volume and decreased ejection fraction in GJB4-deficient zebrafish. by Ryuji Okamoto (614374)

Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

“…(<b>B</b>) ChIP analysis of <i>PC3</i> binding to the <i>Id3</i> promoter in PC12 cells, treated as shown in (<b>A</b>). A scheme above the graph describes the <i>Id3</i> gene and the promoter region analyzed, 700 nt 5′ to the transcription start. …”

Activation, inactivation, and deactivation kinetics differ between Ca_V3.3 WT and variants as well as among the variants. by Yousra El Ghaleb (22075892)

Subjects:

Deletion of TXNIP decreases thioredoxin levels under hyperoxic conditions. by Mohammed A. Abdelsaid (287140)

“…<p>WT and TKO mice were subjected to 5 days hyperoxia (p7–12). …”

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

“…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”

mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes. by Wael Gad (285901)

“…(<b>A</b>) Recombinant mFIZZ1′ and mFIZZ1 co-expressed with hQSOX1b significantly decreased the IL-5 secretion compared to the proteins expressed alone. …”